---
category: news
title: "BioXcel Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update"
excerpt: "SERENITY I & II Phase 3 trials of BXCL501 achieved all primary and secondary endpoints; New Drug Application (\"NDA\") submission to U.S. Food and Drug Administration (\"FDA\") planned for Q1 2021 Initiating the third dose cohort,"
publishedDateTime: 2020-08-14T11:15:00Z
webUrl: "https://www.marketwatch.com/press-release/bioxcel-therapeutics-reports-second-quarter-2020-financial-results-and-provides-business-update-2020-08-14"
type: article
quality: 42
heat: 42
published: false

provider:
  name: MarketWatch
  domain: marketwatch.com
  images:
    - url: "https://smartableai.github.io/artificial-intelligence/assets/images/organizations/marketwatch.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png"
    width: 1200
    height: 630
    isCached: true

secured: "KBArhxB8+EFz1m4yTCEMynyUC4lZi0z5y53b/OVp0+cOdgokNDGHd8Fb/xT/CAg9kWAwKNOQO5EKCVOWMY5vxvXM2bgekAoZcrz3vvXcZuNWRJDpbX/0u0GvEvrAcDzwj2TZ8O+meIIq45xx2+6C0j3spJvb/ttBOHhRLljBned6n1dEmMk475wAG+8VeDihkzMEmhunarrncqBpChg+IRUuID6FnFYWoN3QvO+Ou/wh4qRleK/KVkrKSyK3WARolmxHByN2ITnveETT3s/w7zH38+U212oevZIezq1C1Urr5/Hi5Nbd6hHlw3ztiatKvL7GJ+nCQYN7UjWlGX9EFA==;6vdXt0C4ujcj4f7O3X+m1A=="
---

